Anthracyclines versus No Anthracyclines in the Neoadjuvant Strategy for HER2+ Breast Cancer: Real-World Evidence

BACKGROUND AND OBJECTIVES: Deescalation strategies omitting anthracyclines (AC) have been explored in early human epidermal growth factor receptor 2-positive breast cancer (HER2+ EBC), showing similar efficacy regarding pathological complete response (pCR) and long-term outcomes as AC-containing reg...

Descripción completa

Detalles Bibliográficos
Autores principales: de Pinho, Inês Soares, Luz, Paulo, Alves, Lucy, Lopes-Brás, Raquel, Patel, Vanessa, Esperança-Martins, Miguel, Gonçalves, Lisa, Freitas, Ritas, Simão, Diana, Galnares, Maria Roldán, Fernandes, Isabel, Criado, Silvia Artacho, Casado, Salvador Gamez, Cañada, Jose Baena, Vega, Isabel M. Saffie, Costa, João G., Fernandes, Ana S., de Sousa, Rita Teixeira, Costa, Luís
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10514156/
https://www.ncbi.nlm.nih.gov/pubmed/37479867
http://dx.doi.org/10.1007/s40261-023-01291-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10514156/
https://www.ncbi.nlm.nih.gov/pubmed/37479867
http://dx.doi.org/10.1007/s40261-023-01291-6

Ejemplares similares